Idexx Laboratories (IDXX) | Stock Overview & Key Data

Idexx Laboratories, Inc. | Large-cap | Healthcare

$542.71

0.01%

| Idexx Laboratories Stock Comparison:

Idexx Laboratories vs Thermo Fisher Idexx Laboratories vs Danaher Idexx Laboratories vs Agilent Technologies Idexx Laboratories vs Iqvia Holdings Idexx Laboratories vs Mettler-Toledo Idexx Laboratories vs S&P 500 | Market

Chart Range Statistics Financials Returns Ownership Calculator FAQ

Idexx Laboratories Performance Comparison

Loading chart data...

Idexx Laboratories

Healthcare Sector

S&P 500

View Full Price History

Stock Range

Today's Range

Low: $539.77 High: $546.00

on July 2, 2025

52 Week Range

Low: $356.14 High: $546.39

on April 9, 2025

on July 1, 2025

All-Time High: $706.95 on July 26, 2021

Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights

Key Statistics

Market Cap i $42.1B

EPS i 10.84

P/E Ratio (TTM) i 48.33

Forward P/E i 43.81

P/B Ratio i 29.21

PEG Ratio i 43.81

Div. Yield i N/A

ROE i 59.33%

Beta i 1.548

Debt to Equity i 73.16

Financial Highlights

Profitability

Gross Margin i 62.44%

Operating Margin i 31.70%

Profit Margin i 22.76%

Returns and Earnings

Return on Assets (TTM) i 22.98%

Return on Equity (TTM) i 59.33%

EBITDA i $1.3B

Net Income (TTM) i $895.0M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Idexx Laboratories IDXX	42.13B Large-cap	2.29%	5.41%	29.64%	32.73%	32.73%	10.36%	41.72%	58.56%
Thermo Fisher TMO	152.45B Large-cap	4.23%	6.31%	-12.73%	-19.35%	-19.35%	-24.93%	-26.77%	5.98%
Danaher DHR	140.51B Large-cap	1.84%	6.27%	0.35%	-12.49%	-12.49%	-17.43%	-15.52%	21.32%
Agilent Technologies A	32.99B Large-cap	2.39%	8.46%	5.61%	-9.73%	-9.73%	-6.62%	-3.67%	31.97%
Iqvia Holdings IQV	27.40B Large-cap	2.54%	16.90%	-5.04%	-16.66%	-16.66%	-24.27%	-28.15%	10.45%
Mettler-Toledo MTD	23.98B Large-cap	1.70%	5.62%	4.23%	-1.27%	-1.27%	-12.73%	-3.81%	43.40%

Ownership & Short Interest

Insider Ownership i 0.68%

Institutional Ownership i 97.66%

Shares Short i 3M

Short Ratio i 3.46

Short % of Shares Outstanding i 4.18%

Average 10-Day Volume i 461K

Average 90-Day Volume i 547K

Idexx Laboratories Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Idexx Laboratories would have performed over time.

Investment Amount

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is IDXX's 52-week high and low?

In the last 52 weeks, Idexx Laboratories reached a high of $546.39 (on July 1, 2025) and a low of $356.14 (on April 9, 2025).

What is the market cap and P/E ratio for IDXX?

Curious about Idexx Laboratories's size and valuation? Its market capitalization stands at 42.13B. When it comes to valuation, the P/E ratio (trailing twelve months) is 48.33, and the forward P/E (looking ahead) is 43.81.

Does IDXX pay dividends? If so, what's the yield?

As for dividends, Idexx Laboratories isn't currently offering a significant yield, or that specific data isn't available right now.

Who are Idexx Laboratories's main competitors or similar companies to consider before investing?

When looking at Idexx Laboratories, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Thermo Fisher TMO	152.45B	Healthcare	Diagnostics & Research	-24.93%	-26.77%
Danaher DHR	140.51B	Healthcare	Diagnostics & Research	-17.43%	-15.52%
Agilent Technologies A	32.99B	Healthcare	Diagnostics & Research	-6.62%	-3.67%
Iqvia Holdings IQV	27.40B	Healthcare	Diagnostics & Research	-24.27%	-28.15%
Mettler-Toledo MTD	23.98B	Healthcare	Diagnostics & Research	-12.73%	-3.81%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Idexx Laboratories, Inc.? (e.g., ROE, Debt/Equity)

To get a sense of Idexx Laboratories's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 59.33%, the Debt to Equity ratio from the most recent quarter is 73.16, and its Gross Profit Margin stands at 62.44%.

What is the recent revenue and earnings growth for IDXX?

Looking at Idexx Laboratories's growth, its revenue over the trailing twelve months (TTM) was $4B. Compared to the same quarter last year (YoY), quarterly revenue grew by 3.60%, and quarterly earnings saw a YoY growth of 3.00%.

How much of IDXX stock is held by insiders and institutions?

Wondering who owns Idexx Laboratories stock? Company insiders (like executives and directors) hold about 0.68% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 97.66%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.